Page last updated: 2024-10-31

metyrapone and Erythema

metyrapone has been researched along with Erythema in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Erythema: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Keutel, J1
Marghescu, S1
Teller, W1

Other Studies

1 other study available for metyrapone and Erythema

ArticleYear
[Bloom syndrome. Case report with dermatohistological, endocrinologic, immunologic and cytogenetic studies].
    Zeitschrift fur Kinderheilkunde, 1967, Volume: 101, Issue:2

    Topics: 17-Hydroxycorticosteroids; Adrenocorticotropic Hormone; Birth Weight; Child, Preschool; Chromosome A

1967